Due to the high demand in the Pharmaceutical market, and the rapid growth of highly specialized biopharmaceuticals, Progressive Recovery, Inc. (PRI) is pleased to announce the hiring of Sebastien Dalmagne as PRI’s Business Development Manager supporting its BioPharm Division. Sebastien brings with him many years of experience working in the Pharmaceutical industry, specifically assisting clients specify solutions to manage their waste streams and optimize their effluent decontamination and neutralization systems to support their production facilities.
This is an exciting opportunity to further support the BioPharm market, expanding PRI’s superb reputation, advanced engineering, validatable designs and highly-rated service to tailor solutions for BioPharm. There’s a reason PRI Bio is the number one, trusted choice for high level containment- and I’ll help my clients see that,” says Mr. Dalmagne.
PRI Bio (the bio division of Progressive Recovery, Inc.) will continue to develop innovative solutions to support pharmaceuticals and biologics development, advancements in animal health research, biodefense, academia, and veterinary diagnostic and forensics. With industry-leading flexible, highly customizable, modular effluent and tissue sterilization, PRI Bio offers a treatment system for virtually any application.
PRI Bio’s parent company Progressive Recovery, Inc. (PRI) is one of the world’s largest providers of closed loop solvent management and solvent wash systems, and a custom contract fabricator for a variety of industrial filtration and recycling skids. PRI was founded in 1983, and has maintained a strong reputation for quality and reliability, while gradually broadening its products and services. PRI is an ISO 9001:2008 certified manufacturer, with over 3,000 systems in over 35 countries worldwide, and a large in-house North America support team of traveling service technicians and engineers, with additional support offices in Europe and Asia.
PRI Bio specializes in the design and manufacture of systems for the treatment of biologically hazardous liquid and solid waste for pilot and research facilities, pharmaceutical production, vivarium, veterinary diagnostic laboratories, universities, hospitals, biodefense facilities and more. PRI Bio manufactures Effluent Sterilization and Carcass Sterilization systems, to support ongoing medical advancements while offering a last line of defense for the general public and the environment.
PRI Bio continues to advance the science of pathogen waste treatment, to meet industry challenges including: greater flexibility, faster throughput, larger volumes, small batch volumes, lower costs, pH control, and more.